Achaogen

Lobbying

$87,500 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers through Q3, 2011

Lobbying On Behalf of Achaogen

View all lobbying data for Achaogen Sources: OpenSecrets.org

Federal Spending

3 contracts
Information

Federal grants, contracts and loans are reported by federal agencies using the FPDS and FAADS systems. The data is made available to the public at USASpending.gov. Please note that the completeness and quality of the data varies greatly by agency.

Only grants, contracts and loans with amounts over $1 million are shown.

Because company names are not reported in a standardized manner, we cannot reliably determine the company receiving the contract or award. The results shown here are based on a search for the company name. Individual records may be missed or erroneously included because of name variations. For more information, please see our federal spending methodology page.

covers through USASpending.gov's March 1, 2012 release

Note: Company names in federal spending data are not standardized. The table below is included only as a sample of what is available in the data and has not been reviewed for accuracy or completeness. To investigate the data further, use the links at the bottom of the table.

Type Recipient Name Year Agency Description Amount
contract
Achaogen Incorporated 2011 NOVEL BROAD SPECTRUM THERAPEUTICS AGAINST GRAM-NEGATIVE BACTERIAL THREAT AGENTS R&D EFFORT. $5,256,473
contract
Achaogen Incorporated 2011 NOVEL BROAD-SPECTRUM THERAPEUTICS AGAINST GRAM-NEGATIVE BACTERIAL THREAT AGENTS R&D EFFORT. $3,673,211
contract
Achaogen Incorporated 2011 Novel Broad-Spectrum Therapeutics Against Gram-Negative Bacterial Threat Agents R&D Effort. $1,750,000
View all grant & loan data for Achaogen View all contract data for Achaogen Sources: USASpending.gov